Publicly traded marijuana multistate operators exited regulated cannabis markets through late 2023, continuing a pattern fueled by increased capital costs, high taxes and the slow pace of federal reform.
Marijuana multistate operators continue to flee …
Avis Bulbulyan
Lawsuit casts spotlight on New York’s initial medical cannabis licensing, questions scoring
A new lawsuit sheds light on New York’s licensing of 10 medical cannabis operators in 2015 and 2016, raising questions about how regulators scored the applications and whether other unsuccessful applicants could raise their own legal objections. …